During the past decade, Southeastern Retina Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southeastern Retina Associates" are ""Wet" Age-Related Macular Degeneration" (1 trials), "Exudative Age-Related Macular Degeneration" (1 trials), "Focal Vitreomacular Adhesion" (1 trials) and "Symptomatic Vitreomacular Adhesion" (1 trials). Many other conditions were trialed in "Southeastern Retina Associates" in a lesser frequency.

Most popular intervention types in "Southeastern Retina Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocriplasmin" (1 trials), "Sham injection" (1 trials) and "Squalamine Lactate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Retina Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Southeastern Retina Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southeastern Retina Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Retina Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".